Celularity Inc. Adjustments to Additional Paid in Capital, Other
Celularity Inc. (CELU) reported Adjustments to Additional Paid in Capital, Other of $10.24 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2025-11-14
- Celularity Inc. adjustments to additional paid in capital, other for the quarter ending 2025-09-30 was $10.24M, a 244.85% increase year-over-year.
- Celularity Inc. adjustments to additional paid in capital, other for the quarter ending 2025-06-30 was $501.00K.
- Celularity Inc. adjustments to additional paid in capital, other for the quarter ending 2024-09-30 was $2.97M.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month |
|---|---|---|
| 2025-09-30 | $10.24M 10-Q · filed 2025-11-14 | $10.74M derived: sum of 2 quarters · filed 2025-11-14 |
| 2025-06-30 | $501.00K 10-Q · filed 2025-11-14 | |
| 2024-09-30 | $2.97M 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |